0001140361-16-078260.txt : 20160830
0001140361-16-078260.hdr.sgml : 20160830
20160830210723
ACCESSION NUMBER: 0001140361-16-078260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160826
FILED AS OF DATE: 20160830
DATE AS OF CHANGE: 20160830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FUCHS HENRY J
CENTRAL INDEX KEY: 0001197355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 161861774
MAIL ADDRESS:
STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC
STREET 2: 1245 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc1.xml
FORM 4
X0306
4
2016-08-26
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001197355
FUCHS HENRY J
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2016-08-26
2016-08-26
4
M
0
15000
26.49
A
128878
D
Common Stock
2016-08-26
2016-08-26
4
S
0
15000
95.0616
D
113878
D
Common Stock (Right to buy Common Stock)
26.49
2016-08-26
2016-08-26
4
M
0
15000
0
D
2011-11-12
2021-05-11
Common Stock
15000
50225
D
Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.
The price in column 4 is the weighted average. The price actually received ranged from $94.47 to $95.61. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-08-30